1. PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
   Alia Ghoneum et al, 2019, Cancers CrossRef
2. The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy
   Jing-Zhang Wang et al, 2016, International Immunopharmacology CrossRef
3. Nanoparticle delivery systems to combat drug resistance in ovarian cancer
   Emily M. Miller et al, 2021, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
4. Epigenetic‐mediated immune suppression of positive co‐stimulatory molecules in chemoresistant ovarian cancer cells
   Ercan Cacan, 2017, Cell Biology International CrossRef
5. Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening
   Oya Gursoy Yilmaz et al, 2014, Computational Biology and Chemistry CrossRef
6. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer
   Alia Ghoneum et al, 2021, Seminars in Cancer Biology CrossRef
7. Mechanisms and Modulation of Tumor Microenvironment-Induced Immune Resistance
   Tuna Mutis et al, 2015, Resistance of Cancer Cells to CTL-Mediated Immunotherapy CrossRef
8. The multifaced role and therapeutic regulation of autophagy in ovarian cancer
   Fahimeh Nokhostin et al, 2022, Clinical and Translational Oncology CrossRef
9. The effect of Cordyceps extract and a mixture of Ganoderma lucidum/Agaricus Blazi Murill extract on human endometrial cancer cell lines in vitro
   JENS C. HAHNE et al, 2014, International Journal of Oncology CrossRef
10. Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer
    Jens C. Hahne et al, 2015, Archives of Gynecology and Obstetrics CrossRef